Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Family Medicine | Geriatrics | Gynecology | Internal Medicine | Critical Care | Emergency Medicine | Neurology | Nursing | Journal

Back to Journal Articles

Ischemic Stroke Risk Higher in Women With A-Fib

Last Updated: June 01, 2012.

 

For younger women without vascular disease, risk tends to be higher but doesn't reach significance

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Women with atrial fibrillation have a moderately higher risk of ischemic stroke than men, even after accounting for multiple cofactors for stroke, according to a study published online May 31 in BMJ.

FRIDAY, June 1 (HealthDay News) -- Women with atrial fibrillation have a moderately higher risk of ischemic stroke than men, even after accounting for multiple cofactors for stroke, according to a study published online May 31 in BMJ.

Leif Friberg, M.D., Ph.D., from the Karolinska Institute in Stockholm, and colleagues analyzed the incidence of ischemic stroke in 100,802 patients with atrial fibrillation at any Swedish hospital or hospital-affiliated outpatient clinic between 2005 and 2008.

After a median of 1.2 years of follow-up, the researchers found that ischemic strokes were significantly more common in women than men (6.2 versus 4.2 percent per year), with a hazard ratio of 1.47 in univariate analysis and of 1.18 after adjusting for 35 cofactors for stroke. Increased stroke rates were seen for women in all strata of the congestive heart failure, hypertension, age, diabetes, and prior stroke score. The annual stroke rate in women under 65 with no vascular disease (lone atrial fibrillation) tended to be higher than men but did not reach statistical significance.

"Women with atrial fibrillation have a moderately increased risk of stroke compared with men, and thus, female sex should be considered when making decisions about anticoagulation treatment," Friberg and colleagues conclude.

Several authors disclosed financial ties to the pharmaceutical industry; one author has received funding from different manufacturers of drugs used to treat atrial fibrillation and thrombosis.

Full Text
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Acellular Dermal Matrix Safe, Useful in Breast Reconstruction Next: Gene Variants Impact Smokers' Response to Cessation Therapy

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.